Sirolimus and Afinitor drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sirolimus (sirolimus) and Afinitor (everolimus). Common drug interactions include cough among females and convulsion among males.
The phase IV clinical study analyzes what interactions people have when they take Sirolimus and Afinitor. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.
What is Sirolimus?
Sirolimus has active ingredients of sirolimus. eHealthMe is studying from 11,823 Sirolimus users. Check the latest studies of Sirolimus.
What is Afinitor?
Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 41,680 Afinitor users. Check the latest studies of Afinitor.
17 people who take Sirolimus and Afinitor together, and have interactions are studied.

What are the common drug interactions of Sirolimus and Afinitor, by gender? *:
female:
- Cough
- Ear infection
- Blood glucose increased
- Blood cholesterol increased
- Hypersensitivity
- Sinusitis (inflammation of sinus)
- Red blood cell count increased
- Abnormal behaviour
- Agitation (state of anxiety or nervous excitement)
- Drug level decreased
male:
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Atonic seizures (minor type of seizure)
- Herpangina (mouth blisters)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Pyrexia (fever)
- Stomatitis (inflammation of mucous membrane of mouth)
- Drug ineffective
- Fatigue (feeling of tiredness)
- Vomiting
- Angiofibroma (small, reddish brown or even flesh-coloured, smooth, shiny, 0.1- to 0.3 cm papules present over the sides of the nose and the medial portions of the cheeks)
What are the common drug interactions of Sirolimus and Afinitor, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Headache (pain in head)
- Migraine (headache)
- Nausea (feeling of having an urge to vomit)
- Sinus disorder (disease of sinus)
- Vomiting
10-19:
- Cough
- Pyrexia (fever)
- Atonic seizures (minor type of seizure)
- Blood pressure decreased
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Dyspnoea (difficult or laboured respiration)
- Fall
- Foaming at mouth (excess saliva secretion)
20-29:
- Blood glucose increased
- Red blood cell count increased
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Headache (pain in head)
- Rash
- Rash pruritic (redness with itching)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Drug level increased
- Ear infection
- Blood cholesterol increased
30-39:
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Hyperhidrosis (abnormally increased sweating)
40-49:
n/a
50-59:
n/a
60+:
- Drug ineffective
- Fatigue (feeling of tiredness)
- Hospitalisation
What are the existing conditions these people have? *
- Tuberous Sclerosis (a rare genetic disease that causes benign tumours to grow in the brain and other organs): 8 people, 47.06%
- Angiomyolipoma (most common benign tumour of the kidney): 4 people, 23.53%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 17.65%
- Diarrhea: 2 people, 11.76%
- Carcinoid Tumor: 2 people, 11.76%
- Astrocytoma, Low Grade (low grade tumour of the brain that originate in a particular kind of glial-cells): 2 people, 11.76%
- Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells): 2 people, 11.76%
- Brain Neoplasm Benign (non-cancerous tumour of brain): 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Sirolimus and Afinitor?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Sirolimus and Afinitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sirolimus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Afinitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sirolimus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Afinitor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on sirolimus and everolimus (the active ingredients of Sirolimus and Afinitor, respectively), and Sirolimus and Afinitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Spironolactone and Depakote - a second ago
- Drug interactions of Meloxicam and Soliris - 5 seconds ago
- Drug interactions of Dofetilide and Gabapentin - 7 seconds ago
- Drug interactions of Cinnamon and Actos - 9 seconds ago
- Drug interactions of Palonosetron and Hydrocortisone Sodium Succinate - 9 seconds ago
- Drug interactions of Marinol and Voriconazole - 17 seconds ago
- Drug interactions of Ventolin and Pulmicort Respules - 21 seconds ago
- Back Pain and Convulsion - 22 seconds ago
- Drug interactions of Zide and Catapres-Tts-1 - 28 seconds ago
- Drug interactions of Paliperidone Palmitate and Haldol - 28 seconds ago